CBD Research: DEA Loosens Restrictions for Studying Beneficial Cannabinoid


Whether for greed or science, the DEA has reduced restrictions on  researching the CBD cannabinoid.

Last week rumor, innuendo, and hope filled the air. As the charitable season of Christmas took hold, there was a glimmer of hope that the DEA (Drug Enforcement Administration) could be on the precipice of a historic decision, downgrading the Schedule I status of our favorite medicinal herb.

While that didn’t happen…this did: The United States Drug Enforcement Administration moved to ease the odious constraints surrounding one of the plant’s more beneficial non-psychoactive cannabinoids. Ultimately helping to reduce the research requirements for those who are piloting FDA-sanctioned trials on the CBD cannabinoid – a.k.a cannabidiol.

This long-overdue adjustment will simplify and fast track the overall research process required by the FDA regarding CBD’s potential medical value. As a means of broadcasting this wonderful information to the affected scientific world, the DEA fired off a letter notifying the scientific community of these potent changes.

Effective immediately:

CBD Research: DEA Loosens Restrictions for Studying Beneficial Cannabinoid

CBD Research: DEA Loosens Restrictions for Studying Beneficial Cannabinoid

The DEA notes that under these new changes, “a previously registered CBD clinical researcher who is granted a waiver can readily modify their protocol and continue their research seamlessly. This waiver effectively removes a step from the approval process.”

While this smells like great news at first whiff for the cannabis community, more than a few advocates of real medical marijuana are concerned this move is little more than a slap on the back by the good ol’ boys in the federal government, signaling the moneygrubbing greed mongers of Big Pharma that it’s time to cash in on synthetic CDB.

About Author

Born in Long Beach, raised on the central coast: I surf, dab, burn, and blog – though not necessarily in that order. I'm a husband, a father and a lifelong consumer of connoisseur grade weed. I don't drink alcohol or consume any other "drugs." I consider myself to be living proof that weed is not a gateway drug. If it were, I'd be in some serious trouble. Instead, as a 50-year-old ex-realtor that has been smoking weed for nearly 80% of my life (just did the math) ... I can only say, marijuana is safer than prescription pills or alcohol could ever hope to be for calming what stirs the savage beast.


  1. And lets not forget; the federal government has a patent on CBD oil, patent 6630507 is issued to the US health & human services, so this doesn’t surprise me

      • Charles Waller on

        Exactly. The fact the patent on all cannabinoids, both plant sourced and synthetic, was granted long after patents on nabilone and dronabinol undermines the legitimacy. The only use of the patent to date is complicity of the US DHHS & NIH-OTT is allowing marketing of low grade products containing CBD as “dietary and nutritional supplements”, which avoids stringent FDA oversight and required testing and trials as with pharmaceutical compounds. The corporate entities involved in what has become a “multi-level marketing” (pyramid scheme) enterprise are making money at both ends – from trading in the “penny stocks” of their complicated corporate structure and from grossly overpricing substandard products with low levels of CBD.

  2. A pitiful concession, but where can researchers get federally sanctioned CBD strains? Is the farm at the University of Mississippi breeding the best strains of high CBD? Hell no. The knowledge base for CBD genetics is in Colorado and California. Nothing short of rescheduling or legalization will free the research.

  3. This will specifically allow only the entities that the DEA chooses, in this case GW Pharmaceuticals, to get their pill brand of CBD pushed through. That CBD will be the only type allowed by all of the states passing CBD only and will likely cost 100 times what it should.

    • That’s exactly how I see it. However, industrial HEMP also carries large quantities of CBD and is currently being sold in each state in the US. One company is A subsidiary of Medical Marijuana, Inc. Known as RSHO Real Scientific Hemp Oil made right here in the USA and NOT in Great Britain like GW Pharmaceuticals. Now a lot of people out there that think they know the industry say that Industrial Hemp is not true CBD. That like saying science has been faulty for 1000’s of years and that a water molecule is different in Africa than it is in Canada. CBD is CBD no matter where it comes from. If potatoes had CBD, one could still extract the CBD…get it! RSHO has been working with the FDA for several years on research and so that they can help players within the NFL and the NHL with player brain injuries. The RSHO products are currently saving lives of kids that have seizures and it works. So I say, buy USA made products, not products that are made in a secret building out in the middle of no where like GW Pharmaceuticals. With RSHO you can get on the phone and call them if you have questions or concerns. Check out their website for lab tested certifications of their products.

      • Charles Waller on

        Low grade products previously shown to be contaminated with heavy metals, radioactive material and biological agents. Snake oil, in other words. Grossly overpriced also.

        • Oh Charles, I’m glad you added “Previously”. But that was a smear campaign started by Alan Brochstein that CannLab picked up and ran with the ball without doing any DD what so ever. Alan, the self proclaimed Medical Marijuana guru, can on board within the industry about 3 years ago with preconceived notion’s that everyone within the industry were all fraudster in an illegal industry. “They had to be because it is against the law”…so he states. His first company attack came against Medical Marijuana, Inc. His comment was…”why would anyone invest in a company just because they have the industries as their corporate name. They must be doing something wrong. But company after company that he has recommended has failed or closed their doors. Then, some yahoo in Oregon tried to blackmail MJNA’s spokesperson and he told her that if she didn’t give her cash, he would destroy her and the companies she worked for. Several weeks later, a report came out that that his little girl got sick and that he had the product tested at a reparable lab and that it was “ALL” bad. The Lab in true fashion published the finding, only later to confess that they test were not done incorrectly. The lab is in litigation. Let only hope that the guy in Oregon gets added to the law suit. The interesting thing is, if I am not mistaken, I might still have the copies of the blackmail email’s he sent to the spokesperson. IMHO, my recommendation is to always do your own research and never let people tell you that it’s the bible without calling the company yourself and getting the true facts. Just saying! It will prevent headaches in the long run.

Leave A Reply